Lupus & antiphospholipid syndrome

Comparison of the Systemic Lupus Erythematosus (SLE) Risk Probability Index (SLE Risk Probability Index (SLERPI)) scale against the European League Against Rheumatism/American College of Rheumatology (ACR/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria

LupusPublished Retrospective cohort study

Authors' conclusion

The SLERPI scale could be useful in the diagnosis of SLE, especially in early stages, given its good correlation with other classification scales and its good sensitivity.

Study context

Population
Colombian inpatients and outpatients diagnosed with SLE, registry of two referral hospitals in Bogotá, 2016–2019 (median age 36 years; 82.2% women)
Participants
146 inpatients
Exposure
SLERPI vs 2019 ACR/EULAR and 2012 SLICC classification criteria
Outcome
Correlation between absolute scores of SLERPI, ACR/EULAR and SLICC (Spearman)
Methodological detailsregistry-based, two referral hospitals
  • Registry-based
  • Two referral hospitals

Main finding

As reported in the abstract

Correlation between absolute scores (Spearman)

Spearman correlation

0.76

P = 0.000

SLERPI vs ACR/EULAR · moderately strong correlation

Spearman correlation

0.80

P = 0.000

SLERPI vs SLICC · very strong correlation

Observational data: associations, not effects.

Further findings

Prevalence of SLERPI items

ANA
92%
Immunological disorders
71%
Arthritis
64%

Most used treatments

Corticosteroids
87.6%
Chloroquine
67.8%

Characteristics of patients classified as SLE by SLERPI

Higher incidence of hematological compromise and elevated serological markers such as anti-DNA antibodies; more commonly received corticosteroids and azathioprine; higher prevalence of hypertension

Original publication

Comparison of the SLE Risk Probability Index (SLERPI) scale against the European League Against Rheumatism/American College of Rheumatology (ACR/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria. Lupus. Published 6 March 2024. doi:10.1177/09612033241238053

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.